Access to urban acute care services in high- vs. middle-income countries: An analysis of seven cities

listen audio

Study Justification:
The purpose of this study was to assess the supply of acute care services in seven cities from different economic backgrounds. The study aimed to determine the variation in hospital beds, intensive care unit (ICU) beds, and ambulances per population and per acute illness deaths. The study also aimed to explore the relationship between acute care services supply and gross domestic product (GDP) in these cities.
Study Highlights:
– The supply of hospital beds where intravenous fluids could be delivered varied significantly across the cities, ranging from 72.4/100,000 population in Kumasi to 241.5/100,000 in Boston.
– ICU bed supply showed even greater variation, ranging from 0.4/100,000 population in Kumasi to 18.8/100,000 in Boston.
– Ambulance supply also varied significantly, with more than a 70-fold difference between cities.
– When considering supply relative to disease burden, the variation widened even further. For example, ICU beds varied more than 65-fold from 0.06/100 deaths due to acute illnesses in Kumasi to 4.11/100 in Bogota.
– The study found that hospital bed supply per disease burden was associated with GDP, but ICU supply was not.
Recommendations for Lay Reader and Policy Maker:
– The study highlights the substantial variation in urban acute care services across different economic regions. This information is important for both lay readers and policy makers to understand the disparities in access to acute care services.
– Policy makers should consider the findings of this study when planning and allocating resources for acute care services in their cities. The significant variation in supply suggests a need for targeted interventions to improve access to acute care services in certain areas.
– Lay readers should be aware of the differences in acute care services supply between cities, as this may impact their access to quality healthcare in times of acute illness or emergencies.
Key Role Players:
– Local and regional authorities: They play a crucial role in providing data on hospital beds, ICU beds, and ambulances in their respective cities.
– Collaborators: Local collaborators in each city were responsible for collecting data and providing clarification throughout the data collection process.
– Researchers: The researchers conducted the study, analyzed the data, and drew conclusions based on the findings.
Cost Items for Planning Recommendations:
– Data collection: The cost of collecting data on hospital beds, ICU beds, and ambulances from local and regional authorities, as well as conducting primary data collection when required.
– Analysis: The cost of analyzing the collected data using statistical software and tools.
– Research personnel: The cost of employing researchers and collaborators involved in the study.
– Publication: The cost of publishing the study findings in a scientific journal.
Please note that the provided cost items are general categories and do not represent actual costs. The actual cost of conducting the study and implementing the recommendations would depend on various factors and would need to be determined through detailed planning and budgeting.

The strength of evidence for this abstract is 8 out of 10.
The evidence in the abstract is strong because it presents the findings of a cross-sectional study comparing acute care services supply in seven cities from different economic backgrounds. The study collected standardized data on hospital beds, ICU beds, and ambulances, and expressed the results per population and per acute illness deaths. The variation in supply across cities was analyzed, and the association with gross domestic product (GDP) was examined. The study concludes that urban acute care services vary substantially across economic regions, and cities were poor sources of information, which may hinder their future planning. To improve the evidence, the study could have included more cities and collected data from a larger sample size. Additionally, the study could have provided more details on the methodology and limitations.

Purpose: Cities are expanding rapidly in middle-income countries, but their supply of acute care services is unknown. We measured acute care services supply in seven cities of diverse economic background. Methods: In a cross-sectional study, we compared cities from two high-income (Boston, USA and Paris, France), three upper-middle-income (Bogota, Colombia; Recife, Brazil; and Liaocheng, China), and two lower-middle-income (Chennai, India and Kumasi, Ghana) countries. We collected standardized data on hospital beds, intensive care unit beds, and ambulances. Where possible, information was collected from local authorities. We expressed results per population (from United Nations) and per acute illness deaths (from Global Burden of Disease project). Results: Supply of hospital beds where intravenous fluids could be delivered varied fourfold from 72.4/100,000 population in Kumasi to 241.5/100,000 in Boston. Intensive care unit (ICU) bed supply varied more than 45-fold from 0.4/100,000 population in Kumasi to 18.8/100,000 in Boston. Ambulance supply varied more than 70-fold. The variation widened when supply was estimated relative to disease burden (e.g., ICU beds varied more than 65-fold from 0.06/100 deaths due to acute illnesses in Kumasi to 4.11/100 in Bogota; ambulance services varied more than 100-fold). Hospital bed per disease burden was associated with gross domestic product (GDP) (R 2 = 0.88, p = 0.01), but ICU supply was not (R 2 = 0.33, p = 0.18). No city provided all requested data, and only two had ICU data. Conclusions: Urban acute care services vary substantially across economic regions, only partially due to differences in GDP. Cities were poor sources of information, which may hinder their future planning. © 2013 The Author(s).

We conducted a descriptive cross-sectional study of supply of several measures of acute care services in a convenience sample of seven cities with a population of at least 100,000 from different geographic and economic strata: on the basis of World Bank criteria, two cities from high-income countries (Boston, USA and Paris, France), three from upper middle-income countries (Bogota, Colombia; Recife, Brazil; and Liaocheng, China), and two from lower-middle-income countries (Chennai, India and Kumasi, Ghana). We defined supply of acute care services as the number of each service per 100,000 population and per population-adjusted measure of disease burden. With local collaborators, we determined supply from data provided by local and regional authorities and conducted primary data collection when required. We determined the denominators of population and disease burden from existing census data and the Global Burden of Disease (GBD) project [7]. We chose two denominators because neither is ideal. Population data are more likely to be measured similarly across countries and with reasonable accuracy but fail to reflect the varying demand placed on acute care services by variation in disease incidence. Disease burden is thus better theoretically but is measured less accurately. We obtained approval for the study from the University of Pittsburgh Institutional Review Board (# PRO11110256) and local institutional officials as required for any prospective collection of facilities data. The population count for each city included its urban agglomeration, defined as the population in the city and adjacent suburbs [8]. We obtained the latest urban population estimates (2010–2012) from the United Nations, demographic yearbooks [9, 10], and respective national census and local administrative data [11–16]. The GBD project assesses cause-specific mortality to estimate health loss from diseases, injuries, and risk factors for all regions of the world [17]. Extending that method, we chose the number of deaths due to acute illnesses as our standard metric for disease burden. Our goal was not to measure the total burden, but rather to have a measure, proportional to burden, that permits the calculation of population-adjusted rates of supply of acute care services. The advantage of focusing on mortality is that we could rely on the GBD project, the world’s largest and most comprehensive effort to measure disease burden. The two limitations are that assignment of cause-specific mortality is prone to error and differences in case-fatality rates across cities confound the assumption that deaths are proportional to disease burden (see “Limitations”). We abstracted data from the 2008 GBD project update [7], which estimates the number of deaths per country in multiple categories of diseases. The 2008 data are the latest available at the required level of granularity. Two investigators (NKJA, SM) independently selected all communicable and non-communicable diseases whose burden would potentially be mitigated by acute care services. Disagreements were resolved by consensus of all study investigators. We selected the following illnesses: respiratory infections (otitis media, lower, and upper respiratory infections), injuries (road traffic accidents, poisoning, falls, fires, drowning, self-inflicted injuries, violence due to war and civil conflicts), and other acute illnesses (tuberculosis, diarrheal diseases, childhood-cluster diseases, meningitis, malaria, tropical-cluster diseases, dengue, Japanese encephalitis, nephritis and nephrosis, cardiovascular and respiratory diseases, maternal conditions, and diabetes mellitus). The sum of deaths across all categories was defined as the number of deaths due to acute illnesses. For each city, we estimated the number of deaths due to acute illnesses as number of deaths due to acute illnesses in the country × (city population/country population). We performed similar calculations using GBD age categories of 0–14, 15–59, and 60 years and over. We developed a data collection instrument (see “Appendix”) to gather information on the numbers of hospitals, hospital beds, ICU beds, and ambulances available in each city to serve the general population. Our goal was to create standard definitions applicable for all selected cities. After pilot testing and revision, our final instrument used the following definitions. Hospitals (including pediatric hospitals): those with an emergency department and capable of managing acute community-acquired illnesses, including government and private hospitals that provided substantial public access, as adjudicated by local collaborators. Hospital beds: staffed, acute care, non-neonatal beds capable of delivering intravenous fluids, medications, and oxygen. ICU beds: staffed with higher intensity nursing than available on acute care wards and the ability to provide oxygen therapy, pulse oximetry, vasopressors or invasive hemodynamic monitoring (e.g., ability to measure central venous pressure), and invasive mechanical ventilation. Self-defined ICU beds: as defined by the region or hospital, regardless of whether the definition agreed with our standardized definition. Ambulances: vehicles (including those operated by the fire department) that transport acutely ill patients from home to hospitals and vice versa, excluding vehicles that solely transport patients between hospitals. To obtain data, we identified local collaborators in each city. We circulated data collection instruments via email and held monthly conference calls to provide clarification and updates on the data collection process. Each collaborator collected data between January and September 2012. Collaborators first attempted to obtain data from government sources. If data were unavailable, collaborators conducted web searches and contacted other local data sources or individual hospitals, as required. We kept a log of all efforts to collect data. For each city, we calculated acute care services supply (hospitals, hospital beds, ICU beds, and ambulances) per 100,000 population and per 100 deaths due to acute illnesses. We also calculated disease burden as the total deaths due to all acute illnesses, respiratory infection deaths, and deaths due to injury per 100,000 population. For each disease burden category, we also calculated subtotals by age. We tested using regression statistics for any linear or non-linear relationship between supply of acute care services per 100 deaths and national gross domestic product (GDP) per capita, obtained from the World Bank [18]. Unless otherwise stated, when comparing ICU beds, we used the standardized rather than ‘self-defined’ count. We enumerated the barriers to data collection identified by our local collaborators. All data management and analyses were conducted using SPSS version 19 (IBM, Armonk NY) and Microsoft Excel 2007 (Microsoft, Redmond WA).

N/A

Based on the provided information, here are some potential innovations that could improve access to maternal health:

1. Mobile clinics: Implementing mobile clinics equipped with necessary medical equipment and staffed with healthcare professionals can bring maternal health services directly to communities, especially in areas with limited access to healthcare facilities.

2. Telemedicine: Utilizing telemedicine technology, such as video consultations and remote monitoring, can enable pregnant women to receive prenatal care and consultations from healthcare providers without the need for physical travel to healthcare facilities.

3. Community health workers: Training and deploying community health workers who can provide basic maternal health services, education, and support in remote or underserved areas can help bridge the gap in access to maternal healthcare.

4. Maternal health vouchers: Introducing voucher programs that provide financial assistance for maternal health services can help reduce financial barriers and improve access to quality care for pregnant women.

5. Public-private partnerships: Collaborating with private healthcare providers to expand access to maternal health services can help increase the availability of facilities and resources in areas where public healthcare infrastructure is limited.

6. Health information systems: Implementing robust health information systems that can track and monitor maternal health indicators can help identify gaps in access and enable targeted interventions to improve maternal health outcomes.

7. Transportation solutions: Developing innovative transportation solutions, such as ambulance services or transportation subsidies, can help overcome geographical barriers and ensure timely access to emergency obstetric care for pregnant women in remote areas.

8. Maternal health education and awareness campaigns: Conducting community-based education and awareness campaigns to promote maternal health practices, including prenatal care, safe delivery, and postnatal care, can empower women and families with knowledge and encourage them to seek appropriate healthcare services.

9. Task-shifting and skill-sharing: Training and empowering healthcare workers, including midwives and nurses, to take on expanded roles and responsibilities in providing maternal health services can help address workforce shortages and improve access to care.

10. Integration of maternal health services: Integrating maternal health services with other healthcare programs, such as family planning, HIV/AIDS prevention, and nutrition services, can improve overall access to comprehensive care for women throughout their reproductive lifespan.

These innovations can be tailored and implemented based on the specific needs and context of each region or country to improve access to maternal health services.
AI Innovations Description
The study described in the text focuses on the supply of acute care services in seven cities from different economic backgrounds. The purpose of the study was to assess the variation in access to hospital beds, intensive care unit (ICU) beds, and ambulances in these cities. The researchers collected data on these services per population and per acute illness deaths. The results showed significant variation in the supply of acute care services across the cities, even when adjusted for disease burden. The study also found that the supply of hospital beds was associated with gross domestic product (GDP), but ICU supply was not. The researchers faced challenges in obtaining data from the cities, which could hinder future planning efforts. Overall, the study highlights the need for improved access to acute care services in urban areas, particularly in lower-income countries.
AI Innovations Methodology
The study described in the provided text aimed to assess the supply of acute care services in seven cities from different economic backgrounds. The researchers collected data on hospital beds, intensive care unit (ICU) beds, and ambulances in each city and expressed the results per population and per acute illness deaths. The study found significant variations in the supply of acute care services across the cities, even when adjusted for disease burden.

To improve access to maternal health, the following innovations could be considered:

1. Mobile Clinics: Implementing mobile clinics that can travel to remote areas or underserved communities to provide maternal health services. These clinics can offer prenatal care, postnatal care, and other essential services to pregnant women who may not have easy access to healthcare facilities.

2. Telemedicine: Utilizing telemedicine technology to provide remote consultations and monitoring for pregnant women. This innovation can help overcome geographical barriers and allow healthcare providers to offer guidance and support to women in remote areas.

3. Community Health Workers: Training and deploying community health workers who can provide basic maternal health services and education within their communities. These workers can help bridge the gap between healthcare facilities and pregnant women, especially in rural or underserved areas.

4. Health Information Systems: Implementing robust health information systems that can track and monitor maternal health indicators. These systems can help identify areas with low access to maternal health services and enable targeted interventions to improve access.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could be developed as follows:

1. Define Key Indicators: Identify key indicators that measure access to maternal health, such as the number of prenatal visits, percentage of births attended by skilled healthcare providers, and maternal mortality rate.

2. Baseline Data Collection: Collect baseline data on the identified indicators in the target population or area before implementing the recommendations. This data will serve as a reference point for comparison.

3. Implement Innovations: Implement the recommended innovations, such as mobile clinics, telemedicine, community health workers, and health information systems, in the target population or area.

4. Data Collection Post-Implementation: Collect data on the same indicators after implementing the innovations. This data will reflect the changes in access to maternal health services.

5. Data Analysis: Analyze the collected data to assess the impact of the innovations on the identified indicators. Compare the post-implementation data with the baseline data to determine the extent of improvement in access to maternal health.

6. Evaluation and Adjustment: Evaluate the results and make adjustments to the innovations if necessary. This iterative process will help refine the recommendations and further improve access to maternal health.

By following this methodology, researchers and policymakers can assess the effectiveness of the recommended innovations in improving access to maternal health and make informed decisions for future interventions.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email
Chat Icon DIMA AI Care
×